Trials / Unknown
UnknownNCT06041165
A Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamic Effects of JS401
A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Kinetic Effects in Healthy Volunteers With Normal or Mildly Elevated Triglycerides
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (estimated)
- Sponsor
- Shanghai Junshi Bioscience Co., Ltd. · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to evaluate the safety, tolerability, pharmacokinetcs and pharmacodynamics of single-dose of JS401 in healthy volunteers with normal or mildly elevated triglycerides.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | JS401 | Single dose of JS401 by subcutaneous (sc) injections |
| DRUG | Placebo | Calculated volume to match active treatment |
Timeline
- Start date
- 2023-08-31
- Primary completion
- 2024-06-29
- Completion
- 2024-09-21
- First posted
- 2023-09-18
- Last updated
- 2023-09-18
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06041165. Inclusion in this directory is not an endorsement.